Reference
  1. Killick J, Morisse G, Sieger D, Astier AL. Complement as a regulator of adaptive immunity. Semin Immunopathol. 2018; 1:37-48.
  2. Kumar V. The complement system, toll-like receptors and inflammasomes in host defense: three musketeers’ one target. Int Rev Immunol. 2019; 4:131-156.
  3. Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD. Interactions between coagulation and complement–their role in inflammation. Semin Immunopathol, 2020; 1:151-65.
  4. Haninger-Vacariu N, Aigner C, Kain R, Prohászka Z, Gaggl M, Böhmig GA, et al. Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy. Kidney Med, 2020;, 2: 213-217.
  5. Lokki AI, Haapio M, Heikkinen-Eloranta J. Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report. Front Immunol. 2020; 11:548.
  6. Luque A, Serrano I, Aran JM. Complement components as promoters of immunological tolerance in dendritic cells. Semin Cell Dev Biol. 2019; 85:143-152.
  7. Meuleman T, Cohen D, Swings GM, Veraar K, Claas FH, Bloemenkamp KW. Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage. J Reprod Immunol. 2016; 113:54-60.
  8. Galindo-Sevilla N, Reyes-Arroyo F, Mancilla-Ramírez J. The role of complement in preterm birth and prematurity. J Perinat Med. 2019; 8:793-803.
  9. Chen L, Yue J, Han X, Li J, Hu Y. Ouabain rescues rat nephrogenesis during intrauterine growth restriction by regulating the complement and coagulation cascades and calcium signaling pathway. J Dev Orig Health Dis. 2016; 1:91-101.
  10. Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011; 3:e1001013.
  11. Salmon JE, Heuser C, Triebwasser M, Liszewski Mk, Kavanagh D, Roumenina L, et al. Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome. Exp Hematol. 2016; 5:390-398.
  12. Girardi G. Complement activation, a threat to pregnancy. Semin Immunopathol. 2018; 1:103-111.
  13. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005; 7491:565.
  14. Sjöberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009; 2:83-90.
  15. Webster RO, Hong SR, Johnston RB Jr, Henson PM. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology. 1980; 3:201-219.
  16. Hänsch GM, Seitz M, Betz M. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol. 1987; 3-4:317-320.
  17. Haeger M, Unander M, Andersson B, Tarkowski A, Arnestad JP, Bengtsson A. Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Acta Obstet Gynecol Scand. 1996; 8:695-701.
  18. Ma Y, Kong LR, Ge Q, Lu YY, Hong MN, Zhang Y, et al. Complement 5a-mediated trophoblasts dysfunction is involved in the development of pre-eclampsia. J Cell Mol Med. 2018; 2:1034-1046.
  19. Morgan BP. The membrane attack complex as an inflammatory trigger. Immunobiology. 2016; 6:747-751.
  20. Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol. 2002; 1:458-465.
  21. Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick RM. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia. Am J Reprod Immunol. 2015; 5:437-444.
  22. De Falco M., Penta R., Laforgia V., Cobellis L., De Luca A. Apoptosis and human placenta: expression of proteins belonging to different apoptotic pathways during pregnancy. J Exp Clin Cancer Res .2005;1:25-33.
  23. Gardiner C, Vatish M. Impact of haemostatic mechanisms on pathophysiology of preeclampsia. Thromb Res. 2017; 151 Suppl 1:S48-S52.
  24. Trouw LA, Blom AM, Gasque P. Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol. 2008; 5:1199-1207.
  25. Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, et al. An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. J Immunol. 2010; 7:4420-4429.
  26. Agostinis C, Tedesco F, Bulla R. Alternative functions of the complement protein C1q at embryo implantation site. J Reprod Immunol. 2017; 119:74-80.
  27. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006; 9:2165-2175.
  28. Martin M, Leffler J, Blom AM. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem. 2012; 40:33733-33744.
  29. Sellar GC, Cockburn D, Reid KB. Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1-1p36.3. Immunogenetics. 1992; 3:214-216.
  30. Bobak DA, Gaither TA, Frank MM, Tenner AJ. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J Immunol. 1987; 4:1150-1156.
  31. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J Immunol. 2001; 12:7496-7503.
  32. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol. 1997; 10:4525-4528.
  33. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol. 2001; 5:3231-3239.
  34. Galvan MD, Greenlee-Wacker MC, Bohlson SS. C1q and phagocytosis: the perfect complement to a good meal. J Leukoc Biol. 2012; 3:489-497.
  35. Ogden CA, deCathelineau A, Hoffmann PR. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781-795.
  36. Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RA. Mannosebinding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol. 2005;174:3220-3226.
  37. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002; 1:191-201.
  38. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun. 2007; 23:114-21.
  39. 134.Hosszu KK, Santiago-Schwarz F, Peerschke EI, Ghebrehiwet B. Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity. Innate Immun. 2010; 2:115-127.
  40. Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol. 2012; 11:5682-5693.
  41. Clarke EV, Weist BM, Walsh CM, Tenner AJ. Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol. 2015; 1:147-160.
  42. Yamada M, Oritani K, Kaisho T, Ishikawa J, Yoshida H, Takahashi I, et al. Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur J Immunol. 2004; 1:221-230.
  43. Fraser DA, Laust AK, Nelson EL, Tenner AJ. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J Immunol. 2009; 10:6175-6185.
  44. Teh BK, Yeo JG, Chern LM, Lu J. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol Immunol. 2011; 9-10:1128-1138.
  45. Waggoner SN, Cruise MW, Kassel R, Hahn YS. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway [published correction appears in J Immunol. 2007 Mar 1;1785;:3332]. J Immunol. 2005; 7:4706-4714.
  46. Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Rönnblom L, et al. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 2009; 10:3081-3090.
  47. Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce MG, Ji Y, et al. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood. 2012; 6:1228-1236.
  48. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004; 22:431-456.
  49. Theofilopoulos AN, Gleicher N, Pereira AB, Dixon FJ. The biology of immune complexes and their possible role in pregnancy. Prog Clin Biol Res. 1981; 70:93-114.
  50. Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy. 2002; 1:77-83.
  51. Lokki AI, Heikkinen-Eloranta JK, Laivuori H. The Immunogenetic Conundrum of Preeclampsia. Front Immunol. 2018; 9:2630. Published 2018 Nov 13.
  52. Szala A, Paradowska E, Nowakowska D, Swierzko AS, Dzierzanowska-Fangrat K, Sokolowska A, et al. Mannan-binding lectin-2 MBL2; gene polymorphisms in prenatal and perinatal cytomegalovirus infections. Mol Immunol. 2011; 15-16:2203-2206.
  53. Hayashi M. Aetiology of pre-eclampsia and thrombophilic genetic mutations. Clin Sci Lond;. 2003; 3:269-271.
  54. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol. 1997; 0:4525-8.
  55. Scott D, Botto M. The paradoxical roles of C1q and C3 in autoimmunity. Immunobiology. 2015.
  56. Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011; 4:716-724.
  57. Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, et al. Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss. Clin Immunol. 2019; 203:37-44.
  58. Sutton EF, Gemmel M, Brands J, Gallaher MJ, Powers RW. Paternal deficiency of complement component C1q leads to a preeclampsia-like pregnancy in wild-type female mice and vascular adaptations postpartum. Am J Physiol Regul Integr Comp Physiol. 2020; 6:R1047-R1057.
  59. Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest. 2004; 1:95-99.
  60. Koucký M, Malíčková K, Kopřivová H, Cindrová-Davies T, Hrbáčková H, Černý A ,et al. Low maternal serum concentrations of mannose-binding lectin are associated with the risk of shorter duration of pregnancy and lower birthweight. Scand J Immunol. 2018; 1:e12675.
  61. Kilpatrick DC, Bevan BH, Liston WA. Association between mannan binding protein deficiency and recurrent miscarriage. Hum Reprod. 1995; 9:2501-2505.
  62. Wang FP, Wang MY, Guo XF, Shi RL, Xu SL, Ma SJ, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013; 3:770-774.
  63. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Mannan binding lectin attenuates double-stranded RNA-mediated TLR3 activation and innate immunity. FEBS Lett. 2014; 6:866-872.
  64. Wang M, Zhang Y, Chen Y, Zhang L, Lu X, Chen Z. Mannan-binding lectin regulates dendritic cell maturation and cytokine production induced by lipopolysaccharide. BMC Immunol. 2011; 12:1. Published 2011 Jan 1.
  65. Kilani RT, Mackova M, Davidge ST, Winkler-Lowen B, Demianczuk N, Guilbert LJ. Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae. Reproduction. 2007; 1:257-264.
  66. Pradhan V, Surve P, Ghosh K. Mannose binding lectin MBL; in autoimmunity and its role in systemic lupus erythematosus SLE;. J Assoc Physicians India. 2010; 58:688-690.
  67. Mahto H, Pati A, Sahu SK, Sharma HP, Padhi A, Panda AK. Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis. Lupus. 2020; 10:1227-1237.
  68. Cieslinski JZ, Goeldner I, Skare TL, Nisihara R, Andrade FAD, Velavan TP, et al. Mannose-binding lectin deficiency and miscarriages in rheumatoid arthritis. Autoimmunity. 2017; 7:409-413.
  69. Christiansen OB, Kilpatrick DC, Souter V, Varming K, Thiel S, Jensenius JC. Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand J Immunol. 1999; 2:193-196.
  70. Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol. 2002; 5:1313-1320.
  71. van de Geijn FE, Dolhain RJ, van Rijs W, Willemsen SP, Hazes JM, de Groot CJ. Mannose-binding lectin genotypes are associated with shorter gestational age. An evolutionary advantage of low MBL production genotypes?. Mol Immunol. 2008; 5:1514-1518.
  72. Christiansen OB, Nielsen HS, Lund M, Steffensen R, Varming K. Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses. Hum Reprod. 2009; 2:291-299.
  73. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod. 2002; 3:809-816.
  74. van de Geijn FE, Dolhain RJ, van Rijs W, Hazes JM, de Groot CJ. Mannose-binding lectin genotypes and pre-eclampsia: a case-control study. Hum Immunol. 2007; 11:888-893.
  75. Holmberg V, Schuster F, Dietz E, Sagarriga VJC, Anemana SD, Bienzle U, et al. Mannose-binding lectin variant associated with severe malaria in young African children. Microbes Infect. 2008; 4:342-348.
  76. Reichhardt MP, Lundin K, Lokki AI, Recher G, Vuoristo S, Katayama S, et al. Tuuri Timo.(2019). Complement in Human Pre-implantation Embryos: Attack and Defense. Front Immunol, 10(undefined), 2234.
  77. Goldberg M, Luknar-Gabor N, Keidar R, Katz Y. Synthesis of complement proteins in the human chorion is differentially regulated by cytokines. Mol Immunol. 2007; 7:1737-1742.
  78. Bulla R, Bossi F, Agostinis C, Radillo O, Colombo F, Seta FD, et al. Complement production by trophoblast cells at the feto-maternal interface. J Reprod Immunol. 2009; 2:119-125.
  79. Lokki AI, Aalto-Viljakainen T, Meri S, Laivuori H; FINNPEC. Genetic analysis of membrane cofactor protein CD46; of the complement system in women with and without preeclamptic pregnancies [published correction appears in PLoS One. 2015; 4:e0125449.
  80. Buurma A, Cohen D, Veraar K, Schonkeren D, Claas FH, Bruijn JA, et al. Preeclampsia is characterized by placental complement dysregulation. Hypertension. 2012; 5:1332-1337.
  81. Khera R, Das N. Complement receptor 1: disease associations and therapeutic implications. Mol Immunol. 2009;46:761–772.
  82. Springer T, Galfre G, Secher DS, Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J
  83. Immunol. 1979;9:301–306.
  84. Vik DP, Fearon DT. Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. J Immunol. 1987;138:254–258.
  85. Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Glenn DP, et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood. 2003; 2:611-620.
  86. Mukai R, Okunuki Y, Husain D, Kim CB, Lambris JD, Connor KM. The Complement System Is Critical in Maintaining Retinal Integrity during Aging. Front Aging Neurosci. 2018; 10:15. Published 2018 Feb 15. Published 2018 Feb 15.
  87. Silverman SM, Ma W, Wang X, Zhao L, Wong WT. C3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa. J Exp Med. 2019; 8:1925-1943.
  88. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev. 2005; 4:189-194.
  89. Sacks SH. Complement fragments C3a and C5a: the salt and pepper of the immune response. Eur J Immunol. 2010; 3:668-670.
  90. Wilson JG, Tedder TF, Fearon DT. Characterization of human T lymphocytes that express the C3b receptor. J Immunol. 1983; 2:684-689.
  91. Mouhoub A, Delibrias CC, Fischer E, Boyer V, Kazatchkine MD. Ligation of CR1 C3b receptor, CD35; on CD4+ T lymphocytes enhances viral replication in HIV-infected cells. Clin Exp Immunol. 1996; 2:297-303.
  92. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010; 9:785-797. doi:10.1038/ni.1923
  93. Kolev M, Le Friec G, Kemper C. Complement–tapping into new sites and effector systems. Nat Rev Immunol. 2014; 12:811-820.
  94. Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A. Complement receptor type 1 CR1, CD35; is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. Int Immunol. 2013; 1:25-33.
  95. Mácsik-Valent B, Nagy K, Fazekas L, Erdei A. Complement Receptor Type 1 CR1, CD35;, the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses. Front Immunol. 2019; 10:1493.
  96. Beurskens FJ, van Schaarenburg RA, Trouw LA. C1q, antibodies and anti-C1q autoantibodies. Mol Immunol. 2015; 1:6-13.
  97. Wu J, Ma J, Zhang WH, Di W. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018; 14:885-901. Published 2018 May 11.
  98. Khera R, Das N. Complement Receptor 1: disease associations and therapeutic implications. Mol Immunol. 2009; 5:761-772.
  99. Feinberg BB, Jack RM, Mok SC, Anderson DJ. Low erythrocyte complement receptor type 1 CR1, CD35; expression in preeclamptic gestations. Am J Reprod Immunol. 2005; 6:352-357.
  100. McElroy JJ, Gutman CE, Shaffer CM, Busch TD, Puttonen H, Teramo K, et al. Maternal coding variants in complement receptor 1 and spontaneous idiopathic preterm birth. Hum Genet. 2013; 8:935-942.
  101. Fagerholm SC, Guenther C, Llort Asens M, Savinko T, Uotila LM. Beta2-Integrins and Interacting Proteins in Leukocyte Trafficking, Immune Suppression, and Immunodeficiency Disease. Front Immunol. 2019; 10:254. Published 2019 Feb 19.
  102. Norris GT, Smirnov I, Filiano AJ, Shadowen HM, Cody KR, Thompson JA, et al. Neuronal integrity and complement control synaptic material clearance by microglia after CNS injury. J Exp Med. 2018; 7:1789-1801.
  103. Amarilyo G, Verbovetski I, Atallah M, Grau M, Wiser G, Gil O, et al. iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade. Eur J Immunol. 2010; 3:699-709.
  104. Wang L, Gordon RA, Huynh L, Su X, Min KP, Han J, et al. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity. 2010; 4:518-530.
  105. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol. 2010; 8:734-742.
  106. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med. 2003; 2:206-212.
  107. Luo X, Liu L, Tang N, Lu KQ, McCormick TS, Kang K, et al. Inhibition of monocyte-derived dendritic cell differentiation and interleukin-12 production by complement iC3b via a mitogen-activated protein kinase signalling pathway. Exp Dermatol. 2005; 4:303-310.
  108. Vogt L, Schmitz N, Kurrer MO, Bauer M, Hinton HI, Behnke S, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest. 2006; 10:2817-2826.
  109. Kim S, Iizuka K, Kang HP, Dokun A, French AR, Greco S, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol. 2002; 6:523-528.
  110. Min X, Liu C, Wei Y, Wang N, Yuan G, Liu Dan, et al. Expression and regulation of complement receptors by human natural killer cells. Immunobiology. 2014; 9:671-679.
  111. Liu CF, Min XY, Wang NY, Wang JX, Ma N, Dong X, et al. Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function. Front Immunol. 2017; 8:1602. Published 2017 Nov 20.
  112. Nowatzky J, Manches O, Khan SA, Godefroy E, Bhardwaj N. Modulation of human Th17 cell responses through complement receptor 3 CD11 b/CD18; ligation on monocyte-derived dendritic cells. J Autoimmun. 2018; 92:57-66.
  113. Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J Exp Med. 2007; 7:1519-1524.
  114. Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, et al. A nonsynonymous functional variant in integrin-alphaM; encoded by ITGAM; is associated with systemic lupus erythematosus. Nat Genet. 2008; 2:152-154.
  115. MacPherson M, Lek HS, Prescott A, Fagerholm SC. A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis. J Biol Chem. 2011; 19:17303-17310.
  116. Chow WN, Lee YL, Wong PC, Chung MK, Lee KF, Yeung WS. Complement 3 deficiency impairs early pregnancy in mice. Mol Reprod Dev. 2009; 7:647-655.
  117. Nakamura K, Kusama K, Bai R, Ishikawa S, Fukushima S, Suda Y, et al. Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in mice. PLoS One. 2017; 5:e0178442. Published 2017 May 25.
  118. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765.
  119. Lokki AI, Heikkinen-Eloranta J, Jarva H, Saisto T, Lokki ML, Laivuori H, et al. Complement activation and regulation in preeclamptic placenta. Front Immunol. 2014; 5:312.
  120. Martin Myriam., Blom Anna M.(2016). Complement in removal of the dead - balancing inflammation. Immunol Rev, 2016; 1, 218-232.
  121. 42.Derzsy Z, Prohászka Z, Rigó J Jr, Füst G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol. 2010; 7-8:1500-1506.
  122. Burwick RM, Velásquez JA, Valencia CM, Gutiérrez-Marín J, Edna-Estrada F, Silva JL, et al.Terminal Complement Activation in Preeclampsia. Obstet Gynecol, 2018; 6: 1477-1485.